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A B S T R A C T  
Objective: To analyze treated head and neck malignancies with reference to frequency of cervical metastases and 
frequency of nodal recurrence following neck dissection and/ or radiotherapy for cervical metastases. 
Patients and Methods: This observational prospective study was conducted at ENT Department, Pakistan Institute of 
Medical Sciences, Islamabad over a period of 16 months. Study population was comprised of 15 cases of either gender 
and any age, with treated head and neck primary who developed metastatic neck disease and were included through 
non-probability sampling technique. Patients with primary site recurrence or distant metastases were excluded from the 
study. They were treated with neck dissection, radiotherapy or both for neck disease and followed up for a 1 year. 
Clinical data including age, gender, site and histopathology of treated primary tumor, nodal involvement both clinical and 
histopathological, treatment and post treatment result were recorded. Data was collected, tabulated and analyzed using 
Microsoft excel worksheet. 
Results: Out of total 15 cases, 17% patients were with N1 disease, 33% patients with N2a disease, and 50% were with 
N2b disease. Total 3 (20%) patients received radiotherapy (2 being unfit for surgery and 1 due to refused consent) and 
12 (80%) patients underwent surgery. Out of these 12, 3 underwent RND, 7 MRND and 2 SND. Total 20% (3) developed 
recurrence. 
Conclusion: Combination of RND or MRND and radiotherapy is highly effective in controlling neck disease in controlled 
primary tumors. 
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I n t r o d u c t i o n  
 
Head and neck tumors are quite common,1, 2 majority 
being squamous cell carcinomas with laryngeal 
involvement being the commonest.3 In a local study 
variation in the prevalence was noted in different parts of 
the country.3 Also presentation with metastatic neck 
disease is quite common.4 The status of cervical lymph 
nodes with primary head and neck malignancy has vital 
prognostic significance with increased incidence of distant 
metastases with nodal disease. 5 This demands workup 
for cervical lymph node metastasis and thorough 
management of cervical nodal disease. One of the most 
widely used procedure conventionally was Radical Neck 
Dissection (RND), however in recent years treatment of 
neck disease in head and neck malignancy has been 
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widely debated.  RND, which was popularized by Dr. 
Hayes Martin 6 involves unblock removal of lymph nodes 
of lateral neck along with superficial and deep layers of 
deep cervical fascia, including submandibular, deep 
cervical, posterior triangle and supraclavicular nodes and 
lymphatics along with sternomastoid muscle, internal 
jugular vein and accessory nerve.7 Now surgeons are 
moving away from RND for No and N1 neck, and started 
performing modifications by preserving the accessory 
nerve or other non-lymphatic structures. However, the 
question remains that for advanced neck disease are 
modifications like Modified Radical Neck Dissection 
(MRND) with post-operative radiotherapy adequate. This 
has been agreed by some researchers 8 
Despite the bulk of literature available on the subject, lack 
of uniformity in connection with treatment strategies for 
neck disease still exist and also because there is dearth 
of such studies from this part of Pakistan, therefore, the 
present study is important. 
P a t i e n t s  a n d  M e t h o d s  
This observational prospective study was conducted at 
Department of Otorhinolaryngology and Head and Neck 
Surgery of Pakistan Institute of Medical Sciences, 
Islamabad over a period of 16 months from February 
2005 to June 2006. 
Inclusion criteria was patients with controlled primary 
malignant tumor in the head and neck with cervical nodal 
metastases, of either gender and all age diagnosed and 
managed at the department. Exclusion criteria include 
patients who had un-resectable primary tumor and cases 
of cervical metastases with recurrence at primary site.  
Sampling was done through non-probability sampling 
technique. Total15 patients who met the inclusion criteria 
were included in the study. Chart reviews of these 
patients were done to acquire history and other clinical 
data including age, gender, site and histology of primary 
tumor. For neck metastases the level of lymph nodes, 
their size, mobility, whether ipsilateral, contralateral or 
bilateral was assessed and nodal status was recorded 
using UICC staging. 9 All patients underwent FNAC 
examination to confirm metastases. CT scan was done in 
some patients to see the extent of the metastatic neck 
disease and treatment was planned accordingly. 
Histopathology was confirmed by histopathology reports 
of the patients.  
Out of total 15 patients, RND was performed on 3 
patients, 7 patients underwent MRND and 2 patients 
underwent SupraOmohyoid neck Dissection (SND), while 
another 3 patients were treated with radiotherapy. All the 
patients followed up after treatment for minimum up to 1 
year with special attention to neck node palpation to 
detect any recurrence.  
Data was collected, tabulated and analyzed using 
Microsoft Excel Worksheet. Gender was presented by 
frequency and percentage. Mean, Median and Mode was 
calculated for age of patient at presentation. Variables like 
site and histology of primary tumor site, nodal status 
including level, mobility, FNAC, treatment and post 
treatment results were presented by frequency and 
percentage.  
R e s u l t s  
Among total 15 cases, there was male preponderance 
with 11 males (73 %) and 4 females (27 %) with male to 
female ratio M: F = 2.75: 1.  Their age ranged from 45 to 
75 years with mean age of 57.3 years (Table 1). Common 
tumor sites included Larynx in 5 (33.3%) cases and 
tongue in 4 (26.7%) cases (Table 2). 
Examination revealed that most patients having nodal 
metastasis at level II, followed by level III. Nodes were 
mostly mobile. FNAC confirmed the presence of 
metastatic neck disease which was mainly squamous cell 
variety in 10 (83.4%) cases. Total 12 (80%) patients 
underwent neck dissection. While 3 (20%) patients 
received radiotherapy (A dose of 66 Gy each), among 
them 2 were unfit for surgery and 1 refused surgery.  
Among surgical procedures MRND was the most common 
procedure done 47% (Table 2).  
 
Table 1: Demographic Data of Study Population 
(n=15) 
Gender Male 11(73%) 
 Female 04 (27%) 
Age (Years) Minimum 45 
 Maximum 75 
 Mean 57.3 
 Median 55 
 Mode 50.55 
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Table 2: Frequency of site involvement, level of lymph nodes, histology of primary tumor and treatment given 
for cervical metastasis in studied population (n=15) 
Variables Frequency 
(n) 
Percentage 
(%) 
Primary Tumor Site (n=15)  Larynx 5 33.3 
Tongue 4 26.7 
Lower Alveolar Ridge 2 13.3 
Submandibular Gland 2 13.3 
Nasophrynx 1 6.7 
Skin 1 6.7 
Lymph Node Level (n= 15) Level I 2 13.3 
Level II 6 40 
Level I & II 2 13.3 
Level III 3 20 
Level II & III 1 6.7 
Level V 1 6.7 
Lymph Node Mobility (n=15) Mobile 9 60 
Immobile 6 40 
Histopathology 
(n = 12) 
Squamous Cell Carcinoma 10 83.4 
Adenoid cystic Carcinoma 1 8.3 
Malignant Melanoma 1 8.3 
Treatment (n=15) RND 3 20 
MRND 7 47 
SND 2 13 
Radiotherapy 3 20 
Post Treatment Result  
(n=15) 
No follow up 4 26 
Living without Disease 8 54 
Regional Recurrence 2* 13 
Primary site & Regional  
Recurrence 
1 7 
Dead 1* 7 
* This  one patient with regional recurrence expired 
 
Minimum follow up was maintained for a year. Total 
2(13%) patients developed recurrence in the neck (1 in 
MRND group, and the other 1 in radiotherapy group who 
later expired) in the absence of recurrent primary disease. 
In 1(7%) patient, the recurrence in the neck was 
associated with recurrent primary disease as well. All 
these patients developed recurrence within first 6 months. 
Therefore, total of 12 out of 15 necks (80%) were 
controlled and total 3 (20%) patients had recurrence. 
Total 8 patients (54%) were living without loco regional 
disease with the longest follow up of 16 months for 1 
patient, while 4 (26%) were lost to follow up after first 6 
months. However, one of these lost patients came for 
follow up but after the mentioned study period i.e. of one 
year (Table 2). Total 11 patients received postoperative 
radiotherapy, with a mean dose of 55 Gy (Range 30-66 
Gy), only 2 patients received less than 50 Gy. Total 17%  
 
(2/12) of dissected necks were pathologically N1, 33% 
(4/12) were N2a and 50% (6/12) were N2b (Table 3). 
D i s c u s s i o n  
Head and neck cancers are common all over the world 
occupying 6th 1 and 8th position 2, among whole body 
cancers according to different authors, occurring in 
560000 patients with 380000 deaths per year.10 These 
tumors being predominant in males are mostly seen 
between 50 to 70 years of age.4 Squamous cell 
carinomas (SSC) with laryngeal involvement are the 
commonest.3 According to Ridge JA et al, SSC account 
for > 90% head and neck tumors in the west 4 and in a 
local study, Aziz F et al reported the frequency of SCC 
being the commonest 45.8%, followed by lymphoma  
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(14.5%), basal cell carcinoma (BCC), thyroid carcinoma 
(10.5% each), salivary gland tumors (8.80%), others 
being infrequent. 3 In our study SSC topped the list 
(83.4%) followed by adenoid cystic carcinoma and 
malignant melanoma. Site wise, laryngeal tumors are the 
commonest i.e., 53.5%, followed by pharynx 18.7%, 
tongue 10.71%, oral cavity 4.4% and skin 2.6%, being the 
least common.3 In the present study also larynx and 
tongue were the commonest sites with relative frequency 
of 33.3% and 26.7% respectively and skin being the least 
common with frequency of 6.7%. Head and neck tumors 
show gross variations in incidence in different regions 
globally.  Aziz F et al noted variation in the prevalence in 
different parts of Pakistan as well.3  
Metastatic neck disease is also very common with 43% 
showing involvement of regional nodes, 4 and this also 
drops survival by almost 50%. Cervical nodal status with 
primary head and neck malignancy has vital prognostic 
significance demanding workup and thorough 
management of cervical nodal disease.11,12 RND was the 
most widely used procedure to deal with neck metastasis, 
however this has been widely debated.  RND, which was 
popularized by Dr. Hayes Martin 6, involves enblock 
removal of lateral neck nodes with superficial and deep 
layers of deep cervical fascia, including submandibular, 
deep cervical, supraclavicular and posterior triangle 
nodes and lymphatics along with sternomastoid muscle, 
internal jugular vein and accessory nerve 7. According to 
Saurez, removal fibro fatty tissue of neck bearing lymph 
nodes, without sacrificing the non-lymphatic structures 
was oncologically sound.13 Also, for No and N1 nodal 
status, surgeons have started modifications of the 
procedure by preserving the accessory nerve or other 
non-lymphatic structures to minimize morbidity but to 
maintain oncologic efficacy. However, the question still 
remains that for advanced cases i.e., N2 or N3 (stage IV) 
which have worst prognosis, is MRND with post-operative 
radiotherapy adequate. This has been agreed by some 
researchers.8 It is important to note that modification with 
preservation of spinal accessory avoids the shoulder 
disability.14 Leipzig et al.16 and Sobel et al.14 have shown 
clear correlation between the amount of nerve dissection 
and degree of shoulder dysfunction. Even lesser 
dysfunction was noted when all the three i.e., nerve, 
muscle and vein were preserved during SND and 
functional neck dissection.15 Nerve sparing dissections 
result in significant, but temporary and reversible shoulder 
dysfunction, while RND is followed by profound and 
permanent one.16 Preservation of the spinal accessory 
nerve and if preserved along with sternocleidomastoid 
muscle, result in better shoulder function, protection of 
neck arteries and cosmesis.17,18 Therefore surgeons try to 
preserve accessory nerve etc., when oncologially 
feasible. 
Postoperative radiation therapy is recommended for 
cases with large nodal metastasis and extranodal spread. 
However, a high incidence of local recurrence and distant 
metastasis is noted in these cases. Distant secondaries 
are seen in 10% cases of initial relapse, and 47 % in 
cases with more than three positive nodes.19 
Radiotherapy has also been claimed to have good results 
at some centers. In a study by Bernier and Bataini 20 
achieved a 3-year nodal control rate for No tumours of 98 
%; for N1, 90 %; for N2, 88 %; and for N3, 71% when the 
primary site remained controlled.  
Our neck control rate was of 100% (3/3) for RND and 
86% (6/7) for MRND that are comparable to the 
international studies and it also supports the approach to 
nerve preservation, even in bulky N2 or N3 disease. In 
our study, radiotherapy alone for the neck disease was 
not as effective as surgery followed by radiotherapy and 2 
of 3 cases who received radiotherapy alone developed 
neck recurrence, one of these 2 also developed 
recurrence at primary site. Studies by Richards et al 21, 
Santos et al 21, Pathak et al 22, and Leemans et al 23 as 
well as our study shows that comprehensive neck 
dissection (RND & MRND) and postoperative 
radiotherapy has a high likelihood of controlling disease in 
the ipsilateral neck, as long as disease remains controlled 
at the primary site. 
Table 3: Clinical Versus Pathological Nodal 
Staging 
 
Clinical Stage 
(n = 15) 
Histo-Pathological 
Stage (n =12) 
Number (n%) Number (n%) 
N1 4(26.7) 2(17) 
N2a 8(53.4) 4(33) 
N2b 3(20) 6(50) 
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In correlating our clinical and pathological staging, a 
number of patients were found clinically N1 but 
pathologically N2a and clinically N2a but pathologically 
N2b. Also around 50% of the necks are pathologically 
N2b, suggesting that by the time a solitary mass becomes 
clinically greater than 3 cm, probably metastasis to 
multiple nodes have already occurred. Based on this 
experience, a comprehensive neck dissection for N2 or 
greater disease and postoperative radiotherapy seems 
logical. Though in this study contralateral negative necks 
were treated with radiotherapy alone, however failure of 
control was not noted, indicating success of this 
approach. However, in contrast, Richards et al 8, found 
contralateral neck failure in the absence of primary site 
disease in some patients and they suggested. SND of 
contra lateral negative neck  Follow up with evaluation by 
physician is essential 24 with special attention to neck 
palpation which has a sensitivity and specificity of 60-
70%, is essential element of management of these cases. 
Unfortunately, 4 cases were lost to follow up in this study. 
This study has significant importance since there is dearth 
of such studies from this part of the world, though cervical 
recurrence in is quite common here. The study highlights 
the importance of various surgical, radiotherapeutic or 
combined strategies, which can be adopted for the 
treatment of cervical metastasis. 
C o n c l u s i o n  
Combination of RND and MRND with radiotherapy is 
highly effective in controlling neck disease in the absence 
of persistent or recurrent local disease. Also in our 
experience, MRND appears to be as effective as RND in 
controlling even advanced neck disease, which supports 
the preservation of the spinal accessory nerve whenever 
oncologically feasible. 
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